Inventor · disambiguated record
Tito Serafini
Also filed as: SERAFINI TITO · SERAFINI TITO A · SERAFINI TITO ANDREW
11 granted patents·15 pending applications·211 citations·filing 1993–2022
91Inventor score
Top patents by PatentIndex Score
26 records- 0187US6582936B1Methods for making nucleic acidsUNIV CALIFORNIA·Filed 2000·Granted Jun 24, 2003·29 cites·28 claims
- 0286US11472885B2Antibodies that bind tumor tissue for diagnosis and therapyATRECA INC·Filed 2020·Granted Oct 18, 2022·3 cites·36 claims
- 0385US6441269B1Methods for defining cell typesUNIV CALIFORNIA·Filed 2000·Granted Aug 27, 2002·12 cites·13 claims
- 0479US8513485B2Non human transgenic mammal comprising a transgene comprising a nucleotide sequence encoding a ribosomal protein fused to a peptide tagHEINTZ NATHANIEL·Filed 2011·Granted Aug 20, 2013·2 cites·75 claims
- 0579US6114152AMethods for making nucleic acidsUNIV CALIFORNIA·Filed 1998·Granted Sep 5, 2000·73 cites·21 claims
- 0678US7985553B2Method for isolating cell type-specific mRNAsHEINTZ NATHANIEL·Filed 2002·Granted Jul 26, 2011·5 cites·45 claims
- 0775US5565331ANucleic acids encoding neural axon outgrowth modulatorsUNIV CALIFORNIA·Filed 1993·Granted Oct 15, 1996·27 cites·9 claims
- 0874US6110711AMethod of defining cell types by probing comprehensive expression libraries with amplified RNAUNIV CALIFORNIA·Filed 1998·Granted Aug 29, 2000·42 cites·21 claims
- 0971US2022155319A1Use of nanoexpression to interrogate antibody repertoiresATRECA INC·Filed 2022·Application pending·0 cites
- 1064US2019119670A1Method for isolating cell-type specific mrnasHEINTZ NATHANIEL·Filed 2018·Application pending·0 cites
- 1162US10620219B2Use of nanoexpression to interrogate antibody repertoiresATRECA INC·Filed 2017·Granted Apr 14, 2020·0 cites·7 claims
- 1262US2023140035A1Antibodies that bind tumor tissue for diagnosis and therapyATRECA INC·Filed 2022·Application pending·0 cites
- 1361US2014196176A1Method for Isolating Cell-Type Specific mRNAsHEINTZ NATHANIEL·Filed 2013·Application pending·0 cites
- 1459US2015011405A1Use of Nanoexpression to Interrogate Antigen RepertoiresATRECA INC·Filed 2014·Application pending·0 cites
- 1558US6218526B1Polynucleotide encoding human netrin-1UNIV CALIFORNIA·Filed 1998·Granted Apr 17, 2001·9 cites·5 claims
- 1657US2020355698A1Use of nanoexpression to interrogate antibody repertoiresATRECA INC·Filed 2020·Application pending·0 cites
- 1755US2010160351A1Pharmaceutical compositions and methods for treating hyperuricemia and related disordersNUON THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1852US5824775AHuman netrin-1UNIV CALIFORNIA·Filed 1996·Granted Oct 20, 1998·9 cites·1 claims
- 1946US2010158905A1Combination therapy of arthritis with tranilastNUON THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 2046US2003167497A1Methods for defining cell typesFiled 2002·Application pending·0 cites
- 2146US2003106074A1Collections of transgenic animal lines (living library)Filed 2002·Application pending·0 cites
- 2244US2004167226A1Methods for the treatment of pain and traumatic injury using benzamides and compositions containing the sameFiled 2003·Application pending·0 cites
- 2344US2003051266A1Collections of transgenic animal lines (living library)Filed 2001·Application pending·0 cites
- 2442US2005266435A1VR1 receptors and uses thereofHACKOS DAVID·Filed 2005·Application pending·0 cites
- 2541US2005215646A1Methods for treating multiple sclerosis and pharmaceutical compositions thereforRENOVIS INC·Filed 2005·Application pending·0 cites
- 2631US2011136835A1Combination formulations of tranilast and allopurinol and methods related theretoNUON THERAPEUTICS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tito Serafini files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →